- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +20 more
- Locations
-
- Novartis Investigative Site Essen, Germany
- Novartis Investigative Site Lausanne, Switzerland
- Novartis Investigative Site Zurich, Switzerland
Clinical trial condition
Carcinoma
Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.
8,841 public trials
2,101 recruiting studies
Carcinoma trial results
NCT02138214
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +13 more
- Locations
-
- University of Wisconsin Madison, Wisconsin, United States
NCT01482156
- Conditions
- Adenocarcinoma, Advanced Solid Tumors, Breast Diseases, +20 more
- Locations
-
- Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville, Arkansas, United States
- Washington University School of Medicine Washington University (16) St Louis, Missouri, United States
- Medical University of South Carolina SC Charleston, South Carolina, United States
- Novartis Investigative Site Wilrijk, Belgium
NCT01598077
- Conditions
- Breast Diseases, Breast Neoplasms, Carcinoma, +22 more
- Locations
-
- University of Chicago Medical Center University of Chicago (16) Chicago, Illinois, United States
- Massachusetts General Hospital SC-5 Boston, Massachusetts, United States
- University of Texas/MD Anderson Cancer Center UT MD Houston, Texas, United States
- University of Utah / Huntsman Cancer Institute Huntsman Salt Lake City, Utah, United States
NCT01487785
- Conditions
- Adenocarcinoma, Carcinoma, Digestive System Diseases, +10 more
- Locations
-
- Massachusetts General Hospital Dept. of Mass General Hospital Boston, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center MSKCC - SC New York, United States
- University of Utah / Huntsman Cancer Institute Huntsman UT Salt Lake City, Utah, United States
- Novartis Investigative Site Barcelona, Catalonia, Spain
NCT01822613
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
- Locations
-
- University of Chicago Medical Center Dept of Onc Chicago, Illinois, United States
- Karmanos Cancer Institute Dept of Onc Detroit, Michigan, United States
- University of Texas/MD Anderson Cancer Center Gastrointestinal Med. Oncology Houston, Texas, United States
- Novartis Investigative Site Brussels, Belgium
NCT02082210
- Conditions
- Adenocarcinoma, Advanced Cancer, Bronchial Neoplasms, +31 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Tennessee Oncology PLLC Nashville, Tennessee, United States
NCT00880308
- Conditions
- Advanced Solid Tumor Cancers, Basal Cell Carcinoma, Carcinoma, +12 more
- Locations
-
- University of Pittsburgh Medical Center SC Pittsburgh, Pennsylvania, United States
- Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(5) San Antonio, Texas, United States
- Novartis Investigative Site Barcelona, Catalonia, Spain
- Novartis Investigative Site Zurich, Switzerland
NCT03601390
- Conditions
- Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
- Locations
-
- Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
NCT02988440
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Karmanos Cancer Institute Detroit, Michigan, United States
- Novartis Investigative Site Montreal, Quebec, Canada
- Novartis Investigative Site Essen, Germany
- Novartis Investigative Site Hong Kong